Conference Description:

Drawing on our established 5-year events in the series, the 6th LAFM returns for more content, new case-studies, 50+ speakers, and a brand-new track.

As the only peer led community for R and D operations leaders, from large pharma to start-ups, LAFM is your network to explore asset management and maintenance to help develop redundancy within budget, facility design to optimize space and expand research horizons, strategic sourcing across biopharma, and end-to-end R and D operations and EHS to support smaller-sized or growing biotech, institutes, hospitals, and healthcare organizations.

With the news of facility expansion from the likes of Vertex, Genentech and Novo Nordisk, juxtaposing a funding crunch time for biopharma, there's never been more responsibility put upon all lab operation professionals to ensure science can continue; whether you're optimizing resources or scaling out.

That's why the likes of COO, Cambridge at Eli Lilly, Head of Project Management Global Operations at Seagen and Chief of Staff at Interius Biotherapeutics and are joining the LAFM speaker faculty for the first time to help you benchmark best practices and find novel solutions, no matter your organization size or complexity.

Covering daily firefighting, to advanced strategies to help boost your lab sustainability, and digital transformation to facilitate your inventory tracking and procurement strategy, this is the only end-to-end meeting addressing holistic content coverage across lab operations, facilities, EHS, procurement and lab IT.

Tickets: https://go.evvnt.com/1810753-2?pid=154
Time: 8:00 AM - 4:00 PM

Prices:
Drug Developer Pricing - Conference + Workshop Day: USD 3497.00,
Drug Developer Pricing - Conference Only: USD 2599.00,
Academic Pricing - Conference + Workshop Day: USD 3097.00,
Academic Pricing - Conference Only: USD 2199.00,
Solution Provider Pricing - Conference + Workshop Day: USD 5597.00,
Solution Provider Pricing - Conference Only: USD 3999.00

Speakers: Amber Meriwether, Director, Research Procurement, Astellas Pharma, Angela Hui, Director, Operations, Elektrofi, Barbara Burch, Vice President, Network Lab Services, Hackensack Meridian Health, Bill VandeWeghe, Chief Executive Officer, Copia Scientific, Charles Bruseo, Associate Director, Research Strategy and Operations, BMS, Christine Lavery, Head of Scientific Services, GSK, Craig Doerfert, Senior Director Engineering and Facilities Services, Nutcracker Therapeutics, Curtiss McNair II, Vice President / General Manager of Lab Services, American Oncology Network, Dan O'Connell, Associate Director, Facilities Operations, Alnylam Pharmaceuticals, Dan Scungio, Lab Safety Officer, Sentara Healthcare, Daniel Michaels, Senior Manager, Facilities and Lab Operations, Inozyme Pharma, David Buzzeo, Associate Director, Global Procurement,Takeda, Derek Pu, Director, R and D Procurement, Servier Pharmaceuticals, Divya Krishnamurthy, Director, R and D Operations and Risk Management, Lyndra Therapeutics, Dominic Franey, Executive Director, Global Facilities Management and Lab Equipment Maintenance, Charles River Laboratories, Dora Mitchell, Senior VP of Operations, Chief of Staff, Interius BioTherapeutics, Duncan Parsley, Site Operations Director, GSK, Erika Whyte, Senior Director, Facilities, ROME Therapeutics, Ethan Smith, General Manager, Life Sciences, Nuvolo, Ginena Harkins, Director, Safety, Health and Environment, AstraZeneca, Jake Carr, Lab Operations Manager, University of Tennessee, Knoxville, Jason Bernstein, President, American Laboratory Trading, Jason Nagy, Clinical Lab Safety Support Coordinator, Sentara Healthcare, Javier Morell, Global Managing Director, Integrated Lab Solutions, CBRE, Jeffrey Mackay, Vice President, Facilities and Real Estate, Foundation Medicine, Jennifer Raymond, Senior Manager, Corporate Relations, Seeding Labs, Jim Sweeney, Senior Product Manager, PerkinElmer, Joleen Weese, Associate Director of Environmental, Health, Safety, and Sustainability, Lyell Immunopharma, Julie Almeida, Associate Director, Capital Projects, Ultragenyx Pharmaceutical, Keith Berman, Global Lab Adv Tech Platform Lead, Bayer, Keith Shultis, Head of Project Management Operations Global, Seagen, Kevork Kalaydijan, Senior Director of Sales and Business Development, ZefSci, Kristina Rolleri, Associate Director of Facilities, Alector, Levi Rogers, Sustainability Program Manager, New England Biolabs, Liz Fuller, Facilities Operations Manager, Vertex Pharmaceuticals, Liz Kentish, Managing Director, Kentish and Co, Marisa Capone, Planning and Inventory Management Lead, Pfizer, Mark Brassard, Director, Biopharma Strategic Engagement, PHCbi, Marta Verby, Associate Director of Lab Operations, Deep Genomics, Mary Anne Hallacy, Director of Space Management and Facilities, UC Berkeley, Matt Donelan, Director, Environment Health Safety, Umoja Biopharma, Michael Harrison, Chief Operations Officer, Cambridge, Eli Lilly and Co., Michael Serghiou, Senior Director, Global Head of Discovery Research Procurement, Takeda, Michal Avidan-Gartzman, Vice President Operations, Emendo Biotherapeutics, Michelle Merry, Lab Operations Manager, Caraway Therapeutics, Mike Tarselli, Chief Scientific Officer, TetraScience, Monica Tritsch, Manager, Lab Services, Americas, Enterprise Facilities Management, Johnson and Johnson, Murray Nguyen, Senior Lab Operations Manager, Bolt Biotherapeutics, Nanda Gudderra, Director of Environmental Health and Safety, Sangamo Therapeutics, Nathalie Bitar, Director of Research and Early Development Operations, Alnylam Pharmaceuticals, Raymond Knox, Former Chief Manufacturing Officer (Formerly), Lyndra Therapeutics, Renato Pedroso, Site Engineering Head, Takeda, Ryan Chappell, Laboratory Operations, Scorpion Therapeutics, Sam Cooper, Director of Facilities Operations, Regeneron, Shea Bernard, Facilities Project Manager, Bolt Biotherapeutics, Stephen Powell, Director - Integrated Lab Capital Asset Management, BMS, Taylor Phillips, Associate Director, Lab Operations, Interius BioTherapeutics, Urszula Sharples, Lab Manager, Adimab, Yvonne Tejada, Global Category Manager R and D, Alkermes, Zachary Stanley, Executive Director, Bioversity